AU4804697A - Therapeutic compositions and methods for treating disease states with leukocyte adhesion inhibitor-1 (lai-1), and chemokine beta-11 (ckbeta-11) - Google Patents

Therapeutic compositions and methods for treating disease states with leukocyte adhesion inhibitor-1 (lai-1), and chemokine beta-11 (ckbeta-11)

Info

Publication number
AU4804697A
AU4804697A AU48046/97A AU4804697A AU4804697A AU 4804697 A AU4804697 A AU 4804697A AU 48046/97 A AU48046/97 A AU 48046/97A AU 4804697 A AU4804697 A AU 4804697A AU 4804697 A AU4804697 A AU 4804697A
Authority
AU
Australia
Prior art keywords
ckbeta
lai
methods
disease states
therapeutic compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48046/97A
Inventor
Brent L. Kreider
Haodong Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU4804697A publication Critical patent/AU4804697A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU48046/97A 1996-10-04 1997-10-03 Therapeutic compositions and methods for treating disease states with leukocyte adhesion inhibitor-1 (lai-1), and chemokine beta-11 (ckbeta-11) Abandoned AU4804697A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2776996P 1996-10-04 1996-10-04
US72487196A 1996-10-04 1996-10-04
US08724871 1996-10-04
US60027769 1996-10-04
PCT/US1997/017716 WO1998014477A1 (en) 1996-10-04 1997-10-03 THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING DISEASE STATES WITH LEUKOCYTE ADHESION INHIBITOR-1 (LAI-1), AND CHEMOKINE BETA-11 (Ckβ-11)

Publications (1)

Publication Number Publication Date
AU4804697A true AU4804697A (en) 1998-04-24

Family

ID=26702860

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48046/97A Abandoned AU4804697A (en) 1996-10-04 1997-10-03 Therapeutic compositions and methods for treating disease states with leukocyte adhesion inhibitor-1 (lai-1), and chemokine beta-11 (ckbeta-11)

Country Status (4)

Country Link
EP (1) EP0950066A1 (en)
AU (1) AU4804697A (en)
CA (1) CA2267131A1 (en)
WO (1) WO1998014477A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080199481A1 (en) 2007-02-21 2008-08-21 Astrazeneca Ab Compounds
CN116874608A (en) * 2017-03-27 2023-10-13 诺伊尓免疫生物科技株式会社 Chimeric antigen receptor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840524A (en) * 1992-11-27 1998-11-24 Stichting Rega Vzw Granulocyte chemotactic protein
US5633149A (en) * 1994-12-07 1997-05-27 Incyte Pharmaceuticals, Inc. Polynucleotide encoding novel chemokine expressed in inflamed adenoid
US5605817A (en) * 1995-01-19 1997-02-25 Incyte Pharmaceuticals, Inc. DNA encoding chemokine expressed in fetal spleen
AU1916795A (en) * 1995-02-08 1996-08-27 Human Genome Sciences, Inc. Human chemokine beta-11 and human chemokine alpha-1
EP0833914A4 (en) * 1995-06-05 2003-05-28 Human Genome Sciences Inc Human chemokine beta-11 and human chemokine alpha-1
DK0871664T3 (en) * 1995-10-24 2004-04-26 Smithkline Beecham Corp Mobilization of blood-forming stem cells using a chemokine

Also Published As

Publication number Publication date
CA2267131A1 (en) 1998-04-09
EP0950066A1 (en) 1999-10-20
WO1998014477A1 (en) 1998-04-09

Similar Documents

Publication Publication Date Title
EP0710667B8 (en) Modified oligonucleotides, their preparation and their use
AU687936B2 (en) Medical clip
AU2473995A (en) Occludable catheter
AU2440997A (en) Calixpyrroles, calixpyridinopyrroles and calixpyridines
AU9262598A (en) Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders
AU2390000A (en) Rheological treatment methods and related apheresis systems
AU5362696A (en) Compounds and methods for the dectection of t. cruzi infection
AU4597297A (en) Trans-sodium crocetinate, methods of making and methods of use thereof
AU1235392A (en) Cytokine-induced protein, tsg-14, dna coding therefor and uses thereof
AU3378297A (en) Blood treatment system
AU3691797A (en) Double-stranded dna with cohesive end(s), and method of shuffling dna using the same
AU3480297A (en) Modified mcm-56, its preparation and use
IL109963A0 (en) E2-f1 enzyme and methods for the isolation, purification and use thereof
AU4267396A (en) Modified cannula
EP0776920A3 (en) Polyester-acrylate based binder, process for its preparation and its use
AU5383498A (en) Human chemokine beta-13
AU3979395A (en) DNA sequences and their use
EP0919576A4 (en) Novel copolymer, process for the preparation of the same, and use thereof
AU6533294A (en) Seating arrangements for cycles, exercice cycles, other pedal-powered contrivances and the like contrivances
AU3241895A (en) Apoptosis related protein bcl-y, and methods of use thereof
AU5610198A (en) Compounds and methods for treating and preventing bacterial and viral disease
AU1301797A (en) Polypeptides with interleukin 16 activity, process for the preparation and use thereof
AU3327097A (en) Laminate, process for its preparation and its use
AU3467697A (en) 3'-oximino-2',3'-dideoxynucleosides and derivatives of the same
AU4178497A (en) HTm4, methods of treatment and assays, agonists and antagonists